May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
The Efficacy and Safety of Pneumotrabeculoplasty: Results of a 6-Month, Multicenter Study
Author Affiliations & Notes
  • P. Fogagnolo
    G.B. Bietti Foundation for the Study and Research in Ophthalmology, IRCCS, Rome, Italy
  • L. Rossetti
    Eye Clinic, Department of Medicine, Surgery and Odontoiatry, University of Milan, Milan, Italy
  • M. Marraffa
    Eye Clinic, Department of Neurological and Vision Science, University of Verona, Verona, Italy
  • M. Rolando
    Department of Ophthalmology, University of Genoa, Genoa, Italy
  • M. Ciancaglini
    Ophthalmic Clinic, University of Chieti-Pescara, Chieti, Italy
  • G. Marchini
    Eye Clinic, Department of Neurological and Vision Science, University of Verona, Verona, Italy
  • G. Calabria
    Department of Ophthalmology, University of Genoa, Genoa, Italy
  • L. Mastropasqua
    Ophthalmic Clinic, University of Chieti-Pescara, Chieti, Italy
  • N. Orzalesi
    Eye Clinic, Department of Medicine, Surgery and Odontoiatry, University of Milan, Milan, Italy
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 864. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      P. Fogagnolo, L. Rossetti, M. Marraffa, M. Rolando, M. Ciancaglini, G. Marchini, G. Calabria, L. Mastropasqua, N. Orzalesi; The Efficacy and Safety of Pneumotrabeculoplasty: Results of a 6-Month, Multicenter Study. Invest. Ophthalmol. Vis. Sci. 2007;48(13):864.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: To evaluate the efficacy and safety of pneumotrabeculoplasty (PNT) in ocular hypertensive (OHT) and glaucoma (POAG) patients.

Methods:: This study included 35 patients of 4 Italian academic centers with diagnosis of OHT or POAG and intraocular pressure (IOP) ranging between 20 and 25 mmHg under treatment. Exclusion criteria were: severe glaucoma (mean defect worse than 12 dB), past intraocular surgery or inflammation, corneal or conjunctival abnormalities, any retinopathy. Patients underwent screening (-1 day) and baseline visits (day 0) and visits at days 1, 7, 8, 14, 30, 60, 90, 120, 150, 180; PNT was performed in a randomized eye at day 0 and 7. Safety was addressed at all visits by means of ophthalmic examination and questionnaire; an IOP curve (at 8 and 10 am, noon and 2 pm) was measured at days -1, 60, 120, 180.

Results:: In PNT-eyes, IOP at day 0 was 19.9 ± 2.8 mmHg; after PNT, a statistically significant reduction of IOP occurred at all visits. At days 60, 120, 180, IOP was 17.7 ± 5.2, 18.6 ± 3.9 and 18.9 ± 1.3 mmHg (P = 0.001; 0.005; 0.009 respectively). The rate of non-responder (IOP decrease < 5%) to PNT at 6 months was 9/35 (25%) and the mean IOP decrease was 13.8 ± 7.5%. Side effects occurred in 21/35 (60%) patients and included: foreign body sensation (16/35), conjunctival hyperaemia (9), blurred vision (8). All symptoms were mild, with a mean duration of 2 days (range: 30 minutes - 14 days).

Conclusions:: In this small group of patients, PNT treatment reduced IOP of about 14% over a 6-month interval. Mild side effects were common (60%), but no serious side effects occurred. PNT seems an effective and safe procedure for treatment of glaucoma and ocular hypertension, although confirmation by studies with longer follow-up and larger sample size is mandatory.

Keywords: intraocular pressure • trabecular meshwork 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×